Difference between revisions of "Team:IISc Bangalore/Team"

Line 112: Line 112:
 
<div class="wel1 hvr-hang">
 
<div class="wel1 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Team Head</h4>
+
<h4>nickname</h4>
<p>A. C. ...</p>
+
<p>A. Chakraborty</p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 121: Line 121:
 
<div class="wel2 hvr-hang">
 
<div class="wel2 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<h4>nickname</h4>
<p>Member... </p>
+
<p>A. Krishna </p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 130: Line 130:
 
<div class="wel3 hvr-hang">
 
<div class="wel3 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<h4>nickname</h4>
<p>Member... </p>
+
<p>P. Gangopadhyay</p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 138: Line 138:
 
<div class="wel4 hvr-hang">
 
<div class="wel4 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<h4>nickname</h4>
<p>Member... </p>
+
<p>S. Gopalakrishnan</p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 145: Line 145:
 
</div>
 
</div>
 
<div class="row">
 
<div class="row">
<div class="col-md-4 welcome-grid animated wow slideInLeft animated animated" data-wow-duration="1200ms" data-wow-delay="500ms" onclick="openPerson2()">
+
<div class="col-md-4 welcome-grid animated wow slideInLeft animated animated" data-wow-duration="1200ms" data-wow-delay="500ms" onclick="openPerson5()">
 
<div class="wel2 hvr-hang">
 
<div class="wel2 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<h4>nickname</h4>
<p>Member... </p>
+
<p>A. Prasad </p>
 
</div>
 
</div>
 
</div>
 
</div>
  
<div class="col-md-4 welcome-grid wow slideInUp animated" data-wow-delay=".5s" onclick="openPerson3()">
+
<div class="col-md-4 welcome-grid wow slideInUp animated" data-wow-delay=".5s" onclick="openPerson6()">
  
 
<div class="wel3 hvr-hang">
 
<div class="wel3 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<h4>nickname</h4>
<p>Member... </p>
+
<p>A. Das</p>
 
</div>
 
</div>
 
</div>
 
</div>
<div class="col-md-4 welcome-grid wow slideInRight animated" data-wow-delay=".5s" onclick="openPerson4()">
+
<div class="col-md-4 welcome-grid wow slideInRight animated" data-wow-delay=".5s" onclick="openPerson7()">
  
 
<div class="wel4 hvr-hang">
 
<div class="wel4 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<h4>nickname</h4>
<p>Member... </p>
+
<p>A. Baburaj</p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 172: Line 172:
 
</div>
 
</div>
 
<div class="row">
 
<div class="row">
<div class="col-md-4 welcome-grid animated wow slideInLeft animated animated" data-wow-duration="1200ms" data-wow-delay="500ms" onclick="openPerson2()">
+
<div class="col-md-4 welcome-grid animated wow slideInLeft animated animated" data-wow-duration="1200ms" data-wow-delay="500ms" onclick="openPerson8()">
 
<div class="wel2 hvr-hang">
 
<div class="wel2 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<!-- <h4>Member </h4>
<p>Member... </p>
+
<p>Member... </p> -->
 
</div>
 
</div>
 
</div>
 
</div>
  
<div class="col-md-4 welcome-grid wow slideInUp animated" data-wow-delay=".5s" onclick="openPerson3()">
+
<div class="col-md-4 welcome-grid wow slideInUp animated" data-wow-delay=".5s" onclick="openPerson9()">
  
 
<div class="wel3 hvr-hang">
 
<div class="wel3 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<h4>nickname</h4>
<p>Member... </p>
+
<p>J. Bodosa </p>
 
</div>
 
</div>
 
</div>
 
</div>
<div class="col-md-4 welcome-grid wow slideInRight animated" data-wow-delay=".5s" onclick="openPerson4()">
+
<div class="col-md-4 welcome-grid wow slideInRight animated" data-wow-delay=".5s" onclick="openPerson10()">
  
 
<div class="wel4 hvr-hang">
 
<div class="wel4 hvr-hang">
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
<h4>Member </h4>
+
<!-- <h4>Member </h4>
<p>Member... </p>
+
<p>Member... </p> -->
 
</div>
 
</div>
 
</div>
 
</div>
Line 231: Line 231:
 
     <div class="col-md-6 person1Tabcontent">
 
     <div class="col-md-6 person1Tabcontent">
 
       <a href="javascript:void(0)" class="closebtn" onclick="closeTab()">&times;</a>
 
       <a href="javascript:void(0)" class="closebtn" onclick="closeTab()">&times;</a>
       <h1>Overview</h1>
+
       <h1>Arunavo Chakraborty</h1><hr>
       <p class="whitef">With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical  approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009<a href="#refer">[1]</a>.
+
       <p class="whitef">Year: 3rd,
Despite being in high demand (due to the fact that most recombinant products produced on an industrial scale are therapies for chronic diseases like cancer and diabetes), recombinant products are expensive due to several factors like long and expensive development time, high failure rate (~80%) of the products developed, manufacturing costs requiring expensive technologies and processes (bioreactors, column chromatography, sterile conditions, etc) and the involvement of skilled labor on both the manufacturing and the healthcare provider’s side<a href="#refer">[2]</a>. Treatments with these pharmaceuticals can cost from around 10,000 to 100,000 € per year for a single patient[2]. As scientists and engineers, it seems obvious that our contribution can be most easily and effectively be made at the level of manufacturing costs; to try to bring down the cost of these life-saving products.
+
Major: Chemistry; Minor: Biology<br>
 +
"I am a chemistry enthusiast with a recent inclination toward biology. What excites me the most about field is the incredible plethora of chemical reactions in biological systems that would (and do) give any chemist a run for their money. Currently, the topics that interest me are enzyme mechanics, peptide design and biomimetic chemistry. My (only) other companions are select manga and MMO (note, not RP) games."
 
       <br><span class="readm hvr-ripple-out">Read more</span>
 
       <br><span class="readm hvr-ripple-out">Read more</span>
 
</p>
 
</p>

Revision as of 18:30, 8 October 2016



Team IISc iGem

nickname

A. Chakraborty

nickname

A. Krishna

nickname

P. Gangopadhyay

nickname

S. Gopalakrishnan

nickname

A. Prasad

nickname

A. Das

nickname

A. Baburaj

nickname

J. Bodosa

More about the team

Other team aspects.
×

Arunavo Chakraborty


Year: 3rd, Major: Chemistry; Minor: Biology
"I am a chemistry enthusiast with a recent inclination toward biology. What excites me the most about field is the incredible plethora of chemical reactions in biological systems that would (and do) give any chemist a run for their money. Currently, the topics that interest me are enzyme mechanics, peptide design and biomimetic chemistry. My (only) other companions are select manga and MMO (note, not RP) games."
Read more

×

Bioreactor design

We realized that manufacturing units use expensive and energy expensive machinery [3]. Hence, we engineered our bacteria in such a way that it could do most of the work done by these monstrous machines so that we no longer have to buy them and pay their bills. To increase the yield of the product, we came up with the idea of separating cell growth and target protein production so that when the cells have grown up to a high enough cell density, they shuttle all their energy towards the required protein production [4]. Based on the above ideas, we came up with the design of our bioreactor.

We realized that we would not be able to work on the whole idea this summer so, we focussed on two modules of our design: the Protein production module and the auto-aggregation module leaving the arresting of cell growth for future iGEM teams as a seed for their ideas.
Read more

×

Protein production

Induction synthesis of protein of interest is another important step. Microorganisms in bioreactors are induced at the OD, at which the protein production is maximum. [5] Because of this, factories install sophisticated machinery to keep track of the OD value of the culture so as to know when to induce the production. We wanted our bacteria to know when to start protein production and start it by itself. Hence, we used the lux quorum sensing system to sense this cell density. [6] We have expressed the gene for our protein of interest under the luxI gene so that protein of interest is produced in significant quantities only when the quorum is achieved.(Figure 2) We also wish to tune the quorum sensing system by tweaking with the strength of the promoters involved in quorum sensing.
Read more

×

Auto-aggregation

To achieve cellular aggregation, we use the famous auto-transporter protein, Antigen43 (Ag43). [7] It has shown to cause auto-aggregation of cells when overexpressed. (Figure 3) We plan to exploit this property of Ag43 to substitute centrifugation. We acknowledge previous iGEM teams who have worked on Ag43 (Hokkaido University, 2012; Aberdeen Scotland, 2014 and some more) as we got the BioBricks for Ag43 readily available. We intend to express Ag43 only when the cells have made the product of interest. Hence, we use the diauxic shift in the media to act as a switch for the expression of Ag43.
Read more